Epidemiology and Community Control
Current status of hypertension prevalence, treatment and control rate among young and middle-aged population in China
Wang Xin, Zhou Haoqi, Chen Zuo, Zhang Linfeng, Zheng Congyi, Tian Ye, Shao Lan, Zhu Manlu, Wang Zengwu, Gao Runlin
Published 2022-12-24
Cite as Chin J Cardiol, 2022, 50(12): 1169-1176. DOI: 10.3760/cma.j.cn112148-20220916-00721
Abstract
ObjectiveTo estimate the prevalence, awareness, treatment and control rate of hypertension among young and middle-aged population in China.
MethodsThe analysis was based on the results of 2012—2015 China Hypertension Survey, which was a cross-sectional stratified multistage random sampling survey. A total of 229 593 subjects were included in the final analysis. The data including sex, age, living in urban and rural areas, prevalence of hypertension, history of stroke, family history of coronary heart disease and drinking, physical examination, heart rate were collected. Hypertension was defined as mean systolic blood pressure (SBP) ≥140 mmHg (1 mmHg=0.133 kPa), and (or) diastolic blood pressure (DBP) ≥90 mmHg, and (or) self-report a history of hypertension, and (or) use of antihypertensive medicine within 2 weeks before survey. Prehypertension was defined as SBP between 120-139 mmHg, and (or) DBP between 80-89 mmHg. Control of hypertension was considered for hypertensive individuals with SBP<140 mmHg and DBP<90 mmHg. The prevalence of prehypertension, hypertension, awareness, treatment, control rate were calculated, and the control rate among those with antihypertensive medication was also calculated.
ResultsThe prevalence of prehypertension and hypertension was 43.8% (95%CI: 42.3%-45.4%), and 22.1% (95%CI: 20.8%-23.3%), respectively. The prevalence of prehypertension and hypertension was significantly higher among male than female across different age groups. The awareness, treatment, control rate of hypertension and control rate among treated hypertensive participants were 43.8%, 33.2%, 16.7%, and 40.2%, respectively. The prevalence was higher, and the control rate was lower among individuals with higher heart rate.
ConclusionThe prevalence of prehypertension and hypertension among young and middle-aged population is high, the awareness, treatment and control rate need to be further improved in this population. The prevention and treatment of hypertension should be strengthened in the future to improve the control rate of hypertension in China.
Key words:
Hypertension; Young and middle-aged population; Prevalence
Contributor Information
Wang Xin
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Zhou Haoqi
Department of Biostatistics, School of Public Health, Peking University, Beijing 100083, China
Chen Zuo
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Zhang Linfeng
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Zheng Congyi
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Tian Ye
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Shao Lan
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Zhu Manlu
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Wang Zengwu
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China
Gao Runlin
Department of Prevention and Community Health, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China